drugset / Trial / NCT01881633
A Study of the Tolerability, Safety, and Pharmacokinetics of ISU302 in Healthy Volunteers
RandomizedParallel-groupDouble-blind
Summary
The purpose of this study is to assess the safety, tolerability, and pharmacokinetics of single dosing study with three ascending dose cohorts of ISU302 in healthy subjects.
Timeline
- Start
- 2010-10
- Primary completion
- 2010-11
- Completion
- 2010-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ISU302 | Protein / enzyme biologic | 15 iu/kg | Intravenous |
| Subject | ISU302 | Protein / enzyme biologic | 30 iu/kg | Intravenous |
| Subject | ISU302 | Protein / enzyme biologic | 60 iu/kg | Intravenous |